In reply: We agree with Jayasuriya and colleagues that iron deficiency anaemia may be undertreated. Intravenous iron is recommended when rapid restoration of haemoglobin and iron stores is required, oral iron cannot be tolerated, or poor absorption is expected. The National Patient Blood Management Collaborative aims to prevent transfusion and its complications by optimising haemoglobin and iron stores.1 However, randomised trials do not show evidence for benefit of intravenous iron on all outcomes in all populations, including the need for blood transfusion. A recent large randomised trial found no evidence for benefit in giving intravenous iron preoperatively to patients with anaemia undergoing major abdominal surgery.2
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Australian Commission on Safety and Quality in Health Care. The National Patient Blood Management Collaborative [website]. https://www.safetyandquality.gov.au/national-priorities/pbm-collaborative (viewed Feb 2021).
- 2. Richards T, Baikady RR, Clevenger B, et al. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double‐blind, controlled trial. Lancet 2020; 10259: 1353–1361.
- 3. DeLoughery TG. Safety of oral and intravenous iron. Acta Haematol 2019; 142: 8–12.
- 4. Miles LF, Litton E, Imberger G, Story D. Intravenous iron therapy for non‐anaemic, iron‐deficient adults. Cochrane Database Syst Rev 2019; (12): CD013084.
- 5. Choosing Wisely Australia. What is Choosing Wisely Australia? [Website] https://www.choosingwisely.org.au/what-is-choosing-wisely-australia (viewed Feb 2021).
No relevant disclosures.